In another study, an upsurge in immunosuppressive CD14+/HLA-DRlow/- monocytes was observed in the BM and PB at the end of induction chemotherapy in patients who later relapsed during BCP-ALL treatment. This evidence concerns the gene CD14 and acute lymphoblastic leukemia.